Old Web
English
Sign In
Acemap
>
authorDetail
>
Rebecca Boyce
Rebecca Boyce
Cardiff University
Medicine
Intensive care medicine
Dapagliflozin
cost effectiveness
Algorithm
4
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The cost-effectiveness of dapagliflozin in treating high-risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE-TIMI 58 trial.
2021
Diabetes, Obesity and Metabolism
Phil McEwan
Angharad R. Morgan
Rebecca Boyce
Klas Bergenheim
Ingrid Gause-Nilsson
Deepak L. Bhatt
Lawrence A. Leiter
Peter A. Johansson
Ofri Mosenzon
Avivit Cahn
John P H Wilding
Show All
Source
Cite
Save
Citations (3)
MO876ESTIMATING THE BUDGET IMPACT OF DAPAGLIFLOZIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE FROM A UK PAYER PERSPECTIVE
2021
Nephrology Dialysis Transplantation
Oliver Darlington
Phil McEwan
Rebecca Boyce
Gengshi Chen
Becky Martin
Elisabeth Sörstadius
Juan Jose Garcia Sanchez
N. Rao
Show All
Source
Cite
Save
Citations (0)
FC 111THE SOCIETAL IMPACT OF DELAYED DIALYSIS INITIATION ASSOCIATED WITH DAPAGLIFLOZIN BASED ON THE RESULTS OF DAPA-CKD
2021
Nephrology Dialysis Transplantation
Phil McEwan
Oliver Darlington
Rebecca Boyce
Hiddo J.L. Heerspink
David C. Wheeler
Juan Jose Garcia Sanchez
Show All
Source
Cite
Save
Citations (0)
Cost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: evaluation of a machine learning risk prediction algorithm
2020
Journal of Medical Economics
Nathan R. Hill
Belinda Sandler
Ruth Mokgokong
S. Lister
Thomas Ward
Rebecca Boyce
Usman Farooqui
J Gordon
Show All
Source
Cite
Save
Citations (4)
1